Lung Cancer: Pope Leone’s Diagnosis Highlights Need for Screening
Pope Leone discovered a localized lung nodule at an early stage following routine examinations, bringing renewed public attention to a disease that remains the leading cause of cancer mortality in Italy and globally. According to reporting in corriere.it by Vera Martinella, the diagnosis highlights a persistent challenge in oncology: roughly 70 percent of lung cancer patients receive their diagnoses only after the disease has reached an advanced stage.
Every day in Italy, approximately 115 individuals learn they have lung cancer, totaling nearly 45,000 new diagnoses annually according to corriere.it. Data published in Cancer Epidemiology indicate that in 2025, the country recorded 27,100 new cases among men and 16,400 among women. Mortality remains high, with 35,700 deaths estimated in 2022, comprising 23,600 men and 12,100 women. Mentre il cancro ai polmoni è tipico dei fumatori, una piccola parte delle diagnosi si verifica in individui che non hanno mai fumato.
- Lung cancer accounts for nearly 45,000 new diagnoses each year in Italy, with over 70 percent detected at an advanced stage.
- Low-dose spiral computed tomography (LDCT) serves as the primary screening tool recommended for heavy or former smokers aged 55 and older.
- Advanced molecular profiling using Next Generation Sequencing (NGS) allows clinicians to target specific genetic alterations with biologic therapies and immunotherapy.
Screening Recommendations and Diagnostic Protocols for High-Risk Individuals
To intercept the pathology before clinical symptoms emerge, medical societies and international guidelines advocate for structured screening. The World Health Organization (WHO) updated its recommendations for individuals with significant smoking histories, utilizing the pack-year metric—calculated by multiplying daily packs smoked by the total years of smoking—with a minimum threshold of 20 pack-years. Corriere.it outlines that low-dose computed tomography (LDCT) of the chest is the recommended preventative test for current or former heavy smokers over the age of 55.
LDCT equipment exposes patients to radiation levels up to five times lower than a standard chest CT, remaining entirely non-invasive, rapid, and free of intravenous contrast agents. Clinical trials indicate that structured screening in high-risk groups reduces specific mortality by 20 to 24 percent. When diagnostic evaluation is triggered by symptoms or incidental findings, Massimo Di Maio, president of the Italian Association of Medical Oncology (AIOM), explains via corriere.it that initial assessments typically involve standard chest CT, followed by contrast-enhanced abdominal and brain CT, positron emission tomography (PET) scans, and histological confirmation via bronchoscopy or CT-guided percutaneous biopsy.
Next Generation Sequencing Helps Match Biologic Drugs to Tumors
Management strategies have evolved beyond traditional surgery, chemotherapy, and radiotherapy.
Expanding on targeted approaches, reports indicate that surgical specimens undergo Next Generation Sequencing (NGS) to scan approximately 150 tumor genes, matching identified aberrations to ten active biologic drugs. Reports detail that applying biologic treatments in stages II or III following surgery reduces recurrence rates by up to 80 percent.
Giulia Veronesi, director of thoracic surgery at the San Raffaele Hospital in Milan, emphasizes via corriere.it that detecting carcinomas in early phases yields high definitive cure rates. To advance prevention efforts, the San Raffaele hospital has initiated the ARIA project focused on artificial intelligence in smoking-related disease prevention, supported by the Fondazione Umberto Veronesi ETS.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.